• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Lumito

2.25 SEK+10.32 %22/7 17:29
Less than 1K followers

LUMITO

NGM Growth Market

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+10.32 %
-14.02 %
-15.41 %
-66.22 %
-58.98 %
-96.60 %
-99.21 %
-99.18 %
-98.82 %

Lumito is a Swedish company that develops and markets systems for tissue and biomarker analysis in digital pathology, built on upconverting nanoparticle technology. The company targets healthcare facilities, research and the pharmaceutical sector. The company was formed in 2010 as a spinoff from a research group at Lund University's Department of Atomic Physics and Laser Center. Lumito is headquartered in Lund.

Read more
Market cap
40.43M SEK
Turnover
69.35K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue K

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
20/8
2026

Interim report Q2'26

29/10
2026

Interim report Q3'26

23/2
2027

Annual report '26

Regulatory press release2026-07-22 08:30

Sista dag för handel med uniträtter i Lumito AB:s företrädesemission

Lumito
Press release2026-07-20 12:35

Analyst Group: Analyst Group kommenterar Lumitos positiva resultat från pågående samarbetsprojekt

Lumito
Regulatory press release2026-07-20 10:30

Lumito presenterar positiva resultat från pågående samarbetsprojekt – SCIZYS visar hög känslighet i flera tillämpningar

Lumito

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2026-07-20 10:30

Lumito reports positive results from ongoing collaborative research projects – SCIZYS demonstrates high sensitivity across multiple applications

Lumito
Regulatory press release2026-07-16 11:00

Lumitos grundare och styrelseledamot Stefan Andersson-Engels presenterade vid prestigefyllda Gordon Research Conference 2026

Lumito
Regulatory press release2026-07-16 11:00

Lumito’s founder and Board member Stefan Andersson-Engels presented at the prestigious Gordon Research Conference 2026

Lumito
Press release2026-07-14 13:45

Analyst Group: Analyst Group kommenterar Lumitos lovande resultat från pilotstudien med Offspring Biosciences

Lumito
Regulatory press release2026-07-14 11:00

Lumito och Offspring Biosciences rapporterar lovande inledande resultat från pilotstudie som utvärderar automatiserad plattform för immunhistokemi

Lumito
Regulatory press release2026-07-14 11:00

Lumito and Offspring Biosciences report promising initial results from pilot study evaluating automated immunohistochemistry platform

Lumito
Regulatory press release2026-07-13 08:30

Teckningsperioden i Lumito AB:s företrädesemission av units inleds idag

Lumito
Press release2026-07-09 12:20

Analyst Group: Analyst Group kommenterar Lumitos pilotprojekt med Navinci Diagnostics

Lumito
Regulatory press release2026-07-09 09:00

Lumito och Navinci inleder pilotprojekt – lovande initiala resultat från utvärdering av kombinerad teknologi

Lumito
Regulatory press release2026-07-09 09:00

Lumito and Navinci initiate pilot project – promising initial results from evaluation of combined technology

Lumito
Regulatory press release2026-07-08 11:45

Lumito AB offentliggör informationsmemorandum med anledning av företrädesemission av units

Lumito
Regulatory press release2026-07-07 12:25

Extra bolagsstämma i Lumito AB (publ) den 7 juli 2026

Lumito
Regulatory press release2026-07-06 23:15

Lumito AB offentliggör villkor i företrädesemissionen av units om cirka 30 MSEK

Lumito
Regulatory press release2026-07-01 08:30

Lumito utser Pascal Bamford till ny ordförande i Scientific Advisory Board

Lumito
Regulatory press release2026-07-01 08:30

Lumito appoints Pascal Bamford as new Chair of the Scientific Advisory Board

Lumito
Press release2026-06-25 13:55

Analyst Group: Analyst Group kommenterar Lumitos deltagande och vetenskapliga presentationer vid European Congress of Pathology 2026

Lumito
Regulatory press release2026-06-25 10:00

Lumito presenterar två vetenskapliga posters och ställer ut på European Congress of Pathology 2026 i Stockholm

Lumito